Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Am J Surg Pathol. 2020 Jun;44(6):729–737. doi: 10.1097/PAS.0000000000001439

Table 1.

Head and neck GLI1-positive mesenchymal tumors: clinicopathologic, immunophenotypic and molecular characteristics.

Molecular profile Clinical characteristics Pathologic features and immunoprofile
GLI1 alteration (12q13.3) CDK4 (12q14.1) MDM2 (12q15) Fusion Partner Age Sex Primary site LR/ DM Status at last FU FU period (months) MI Necrosis S100 SOX10 CD56 SMA AE1/3 EMA STAT6 CDK4 MDM2
1 Amp. Amp. Amp. 39 M Neck Yes AWD 36 7 Yes + - +++ +++ ++ - - + +
2 Amp. Amp. Amp. 46 F Tongue No NED 3 0 No + - +++ ++ - - - +++ +
3 Amp. Amp. Amp. 65 M Tongue NA NA NA 5 No - - ND - - - +++ +++ +++
4 Amp. Amp. Amp. 60 M Tongue NA NA NA 11 No + ND ND - ND ND + ND ND
5 Fusion PTCH1 32 F Subm. Yes AWD 104 6 Yes +++ ND ND - - + ND ND ND
6 Fusion PTCH1 38 M Tongue No NED 2 1 No ++ - +++ - - ND ND ND ND
7 Fusion ACTB 37 M Neck/subm. No NED 30 0 No - ND +++ + - ND - - +
8 Fusion ACTB 1 M Tongue No NED 2 4 No ND ND ND - ND ND ND ND ND
9 Fusion ACTB 28 M Tongue NA NA NA 0 No ++ - ND + - - ND ND ND
10 Fusion ACTB 14 M Tongue NA NA NA 0 No - ND ND ND - ND ND ND ND
11 Fusion MALAT1 56 F Tongue NA NA NA 8 No - - ND - + ND ND ND ND

FU: follow up; MI: mitotic index (per 10 high power fields); SMA: smooth muscle actin; AE1/3: cytokeratin AE1/AE3; EMA: epithelial membrane antigen; Amp.: Amplification; M: male; F: female; Subm.: submandibular gland; LR: local recurrence; DM: distant metastasis; AWD: alive with disease; NED: no evidence of disease; NA: not available; ND: not done; +++: diffuse and strong immunopositivity; ++: Patchy or multifocal immunopositivity; +: focal or weak immunopositivity; -: negative.